Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
73,943,049
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
38,539,321
-
Shares change
-
+38,510,597
-
Total reported value, excl. options
-
$384,225,008
-
Value change
-
+$383,938,572
-
Number of buys
-
100
-
Price
-
$9.97
Significant Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q2 2024
102 filings reported holding CATX - Perspective Therapeutics, Inc. - COMMON STOCK as of Q2 2024.
Perspective Therapeutics, Inc. - COMMON STOCK (CATX) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,539,321 shares
of 73,943,049 outstanding shares and own 52.12% of the company stock.
Largest 10 shareholders include COMMODORE CAPITAL LP (4,657,345 shares), JANUS HENDERSON GROUP PLC (4,443,667 shares), BlackRock Inc. (3,485,946 shares), Avidity Partners Management LP (3,037,668 shares), VANGUARD GROUP INC (2,921,268 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,817,763 shares), Octagon Capital Advisors LP (1,580,249 shares), MARSHALL WACE, LLP (1,283,942 shares), GEODE CAPITAL MANAGEMENT, LLC (1,034,550 shares), and STATE STREET CORP (997,427 shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.